COMMUNIQUÉS West-GlobeNewswire

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

22/02/2024 - 12:00

STAFFORD, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is [...]

Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally

22/02/2024 - 10:00

ORION CORPORATION PRESS RELEASE 22 FEBRUARY 2024 at 11.00 EET Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally Orion Corporation and Save the Children [...]

Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline

22/02/2024 - 09:51

MELBOURNE, Australia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended 31 December 2023. All figures are in AUD$ [...]

BioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026

22/02/2024 - 07:31

February 22, 2024 Announcement no. 03 BioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026 COPENHAGEN, DENMARK and BOSTON, MA, February 22, 2024, (GLOBE NEWSWIRE) – [...]

argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024

22/02/2024 - 07:00

February 22, 2024 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that [...]

Malaysia: Redefining Cancer Treatment Standards

22/02/2024 - 03:33

Embark on a Journey of Cutting-Edge Treatments and Research Collaboration KUALA LUMPUR, Malaysia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- As the world marks Cancer Awareness Month, Malaysia has made significant strides in the [...]

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

21/02/2024 - 23:00

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6 Company to Host Conference Call with Live Q&A, March 6, 2024 at 4:30pm ET / 22:30 CET IRVINE, CA, and HERSTAL [...]

Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million

21/02/2024 - 22:47

FREEHOLD, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (NYSE American: CHRO) (“Chromocell”, “our”, “us” or the “Company”), a clinical-stage biotech company focused on developing and [...]

Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results

21/02/2024 - 22:30

BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023. Three-Month Periods Ended December 31, [...]

Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer

21/02/2024 - 22:15

Caroline Germa, M.D., an accomplished senior executive and medical oncologist, brings over 25 years of pharmaceutical and drug development expertise Dr. Germa will drive clinical development strategy and oversee the [...]

ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

21/02/2024 - 22:05

Conference Call Scheduled for February 28, 2024, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end [...]

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

21/02/2024 - 22:05

Management will also participate in two upcoming healthcare conferences SALT LAKE CITY, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will [...]

Seer to Participate in the TD Cowen 44th Annual Health Care Conference

21/02/2024 - 22:05

REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be [...]

Ocugen to Present at 2024 BIO CEO & Investor Conference

21/02/2024 - 22:05

MALVERN, Pa., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and [...]

Longeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024

21/02/2024 - 22:05

MIAMI, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that [...]

Predictive Oncology to Participate in Upcoming Investor Conferences

21/02/2024 - 22:05

PITTSBURGH, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive Officer, will [...]

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

21/02/2024 - 22:05

Clinical Validation of the Brain Model Published Online in the Journal NeuroImage SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and [...]

NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders

21/02/2024 - 22:05

LANGHORNE, Pa., Feb. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]

UFC Phenom Marlon “Chito” Vera Dives Into The World of Infused Beverages With MAISON BLOOM

21/02/2024 - 22:04

Vera Joins the Leader in Premium MALTernative TM Beverages and Embraces Drinking Different SAN FRANCISCO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- via IBN – Marlon "Chito" Vera, renowned UFC fighter and entrepreneur, has taken [...]